The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.

Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.

AbbVie and ADARx Pharmaceuticals have signed a collaboration and license option agreement to develop small interfering RNA ...

FAMAR Group, a CDMO, has signed an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma.

The company also appointed Pete Buzy, former President and CEO of Catalent Cell & Gene Therapy, to its Board of Directors.

The partnership combines AKBA’s industry knowledge and product expertise with PeptiSystems’ next-generation synthesizers.

Lonza has appointed Andreas Bohrer to the newly created role of Chief Legal & Corporate Affairs Officer. Effective 1 July ...

This will support the development of mRNA-based vaccines and improve access in low- and middle-income countries.